William Townsend
-
- Lymphoma Diagnosis and Treatment 40
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 23
- Oncology top 5%
- CAR-T cell therapy research 21
- Viral-associated cancers and disorders 11
- Ophthalmology top 5%
- Immunology top 10%
- Biosimilars and Bioanalytical Methods 5
-
- Monoclonal and Polyclonal Antibodies Research 13
-
- CNS Lymphoma Diagnosis and Treatment 6
-
- Retinoids in leukemia and cellular processes 5
- Co-authors
- Lorenz E. ZimmermanRamon L. FontDavid C. LinchElizabeth H. PhillipsRobert MarcusMichael HeroldWolfgang HiddemannTom Moore
- Journals
- Blood (18 papers)Journal of Clinical Oncology (5 papers)American Journal of Ophthalmology (5 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
William Townsend
65 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Pathology and Forensic Medicine 897
- Genetics 365
- Oncology 877
- Ophthalmology 171
- Immunology 375
Countries citing papers authored by William Townsend
This map shows the geographic impact of William Townsend's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Townsend with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Townsend more than expected).
Fields of papers citing papers by William Townsend
This network shows the impact of papers produced by William Townsend. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Townsend. The network helps show where William Townsend may publish in the future.
Co-authorship network
The 25 scholars most cited alongside William Townsend, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 64 | |
| 7 | 2023 | 27 | |
| 8 | 2023 | 1 | |
| 9 | 2022 | 3 | |
| 10 | 2021 | 5 | |
| 11 | 2020 | 122 | |
| 12 | 2018 | 3 | |
| 13 | 2017 | 3 | |
| 14 | 2017 | 3 | |
| 15 | Obinutuzumab for the First-Line Treatment of Follicular Lymphomabreakdown → | 2017 | 461 |
| 16 | 2017 | 11 | |
| 17 | 2012 | 92 | |
| 18 | 2011 | 12 | |
| 19 | 2011 | 1 | |
| 20 | 1997 | 122 |
About William Townsend
William Townsend is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology, having authored 68 papers that have together received 1.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (40 papers), Chronic Lymphocytic Leukemia Research (23 papers), CAR-T cell therapy research (21 papers), Monoclonal and Polyclonal Antibodies Research (13 papers), Viral-associated cancers and disorders (11 papers), CNS Lymphoma Diagnosis and Treatment (6 papers), Retinoids in leukemia and cellular processes (5 papers) and Biosimilars and Bioanalytical Methods (5 papers). The work is most often cited by research in Pathology and Forensic Medicine (897 citations), Genetics (365 citations) and Oncology (877 citations). William Townsend has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Lorenz E. Zimmerman, Ramon L. Font, David C. Linch, Elizabeth H. Phillips, Robert Marcus, Michael Herold, Wolfgang Hiddemann, Tom Moore, John F. Seymour and Wolfram Klapper. Their work appears in journals such as Blood, Journal of Clinical Oncology, American Journal of Ophthalmology, British Journal of Haematology and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.